Epigral Balance Sheet Health
Financial Health criteria checks 3/6
Epigral has a total shareholder equity of ₹12.5B and total debt of ₹9.6B, which brings its debt-to-equity ratio to 76.8%. Its total assets and total liabilities are ₹27.9B and ₹15.4B respectively. Epigral's EBIT is ₹3.6B making its interest coverage ratio 4.9. It has cash and short-term investments of ₹68.0M.
Key information
76.8%
Debt to equity ratio
₹9.63b
Debt
Interest coverage ratio | 4.9x |
Cash | ₹67.96m |
Equity | ₹12.54b |
Total liabilities | ₹15.40b |
Total assets | ₹27.94b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543332's short term assets (₹5.0B) do not cover its short term liabilities (₹7.8B).
Long Term Liabilities: 543332's short term assets (₹5.0B) do not cover its long term liabilities (₹7.6B).
Debt to Equity History and Analysis
Debt Level: 543332's net debt to equity ratio (76.2%) is considered high.
Reducing Debt: 543332's debt to equity ratio has reduced from 79.1% to 76.8% over the past 5 years.
Debt Coverage: 543332's debt is well covered by operating cash flow (41.3%).
Interest Coverage: 543332's interest payments on its debt are well covered by EBIT (4.9x coverage).